BUZZ-Australia's EVE Health Group jumps on snagging regulatory wins
Reuters
Jul 21, 2025
BUZZ-Australia's EVE Health Group jumps on snagging regulatory wins
** Shares of EVE Health Group EVE.AX rise 6.7% to A$0.032, their biggest intraday pct gain since July 4
** The pharma co satisfies the regulatory requirements to enable prescription access to its Libbo and Dyspro products in Australia
** Company to now proceed with commercial launch earlier than anticipated
** Libbo is an oral soluble film containing tadalafil, while Dyspro is a cannabinoid-based pastille formulation
** YTD, shares down 20%
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.